Discontinued — last reported Q4 '25
Short-Term Investments
Current AssetsEli Lilly Short-Term Investments decreased by 28.5% to $121.60M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.6%, from $149.40M to $121.60M. Over 4 years (FY 2020 to FY 2024), Short-Term Investments shows an upward trend with a 59.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
High levels indicate strong cash generation exceeding immediate operational needs; a sharp decline might suggest a shift toward long-term projects or acquisitions.
Detailed definition
Marketable securities and debt instruments that the company intends to sell or that will mature within one year. This me...
Peer comparison
Commonly high in the software industry where low capital intensity leads to significant excess capital.
short_term_investmentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.20M | $37.10M | $90.10M | $109.10M | $113.80M | $124.70M | $144.80M | $123.40M | $134.60M | $113.10M | $109.10M | $126.10M | $140.40M | $149.40M | $154.80M | $127.40M | $170.10M | $121.60M |
| QoQ Change | — | -27.5% | +142.9% | +21.1% | +4.3% | +9.6% | +16.1% | -14.8% | +9.1% | -16.0% | -3.5% | +15.6% | +11.3% | +6.4% | +3.6% | -17.7% | +33.5% | -28.5% |
| YoY Change | — | — | — | — | +122.3% | +236.1% | +60.7% | +13.1% | +18.3% | -9.3% | -24.7% | +2.2% | +4.3% | +32.1% | +41.9% | +1.0% | +21.2% | -18.6% |
Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Eli Lilly's short-term investments?
- Eli Lilly (LLY) reported short-term investments of $121.60M in Q3 2025.
- How has Eli Lilly's short-term investments changed year-over-year?
- Eli Lilly's short-term investments decreased by 18.6% year-over-year, from $149.40M to $121.60M.
- What is the long-term trend for Eli Lilly's short-term investments?
- Over 4 years (2020 to 2024), Eli Lilly's short-term investments has grown at a 59.0% compound annual growth rate (CAGR), from $24.20M to $154.80M.
- What does short-term investments mean?
- Investments like stocks or bonds that the company plans to turn into cash within a year.